document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
1128
document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
document
June 1, 2012 — 00:00
Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.
document
May 31, 2012 — 00:00
This article proposes a mathematical modeling of longevity and an analysis of longevity risk in the field of demographics and life insurance.
Press Releases
SCOR Global Life's Embedded Value results of 2011.
Press Releases
SCOR's first quarter of 2012 results.
document
May 3, 2012 — 00:00
SCOR records net income of EUR 104 million in the 1st quarter 2012, confirming the dynamism of its franchise. SCOR Global Life Embedded Value grows by 50% to EUR 3.3 billion.
document
May 3, 2012 — 00:00
SCOR records net income of EUR 104 million in the 1st quarter 2012, confirming the dynamism of its franchise. SCOR Global Life Embedded Value grows by 50% to EUR 3.3 billion.
document
May 3, 2012 — 00:00
SCOR Global Life Embedded Value reaches EUR 3.3 billion in 2011 (EUR 18.0 per share), continuing to provide the SCOR group with significant earnings and strong capital repatriation.
document
May 3, 2012 — 00:00
SCOR Global Life Embedded Value reaches EUR 3.3 billion in 2011 (EUR 18.0 per share), continuing to provide the SCOR group with significant earnings and strong capital repatriation.
document
May 2, 2012 — 00:00
A.M. Best has upgraded the Issuer Credit Ratings (ICR) of SCOR SE and its main subsidiaries from “a” to “a+”. They have also affirmed the Financial Strength Ratings of “A” (Excellent).
